Evaluation of Validity of Lipoprotien(a) as a Diagnostic Test for Coronary Heart Disease and the Stegnotic Degree of Coronary Artheroscle-
- VernacularTitle:脂蛋白(a)用于冠状动脉造影病变诊断的评价
- Author:
Zengrui LUN
;
Xiangwu JI
;
Xiaoli HAN
;
Jingbo SHAO
;
Aiyuan ZHANG
- Publication Type:Journal Article
- Keywords:
Coronary heart disease;
Coronary angioeraphv;
Lipoprotein( a)
- From:
Journal of Medical Research
2006;0(11):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the validity of lipoprotien(a) [Lp(a)] concentration as diagnostic test for coronary heart disease (CHD) and stegnotic degree of coronary artherosclerosis. Methods 416 cases of patients who were assessed with coronary angiography were divided into four groups according to the stegnotic degree of coronary artherosclerosis. There were no stenosis and lipid plaque group, single branch group, double branch group, three branch and suffusive stenosis group. TC, HDL - C, LDL - C, ApoAl, ApoB, Lp(a) were examined in early morning fasting for 12 hours after the next admission day. Other risk factors were also recorded, such as hypertension. Results When Lp(a) concentration was used alone to diagnose CHD, the best cutoff value was 15 mg/dl. The crude agreement was 58.2% , the sensitivity was 57.5% , and the specificity was 59.3% . Along with the stegnotic degree of coronary artherosclerosis heavier, the levels of the crude agreement and the sensitivity had a indreasing trend,and levels of the false negative rate had a deoreasing trend. Conclusion The validity of Lp(a) concentration as diagnostic test for CHD is not satisfactory.
